Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Cetuximab |
Trade Name | Erbitux |
Synonyms | IMC-C225 |
Drug Descriptions |
Erbitux (cetuximab) is a monoclonal antibody directed against EGFR, which inhibits signal transduction and cell proliferation (PMID: 28695301). Erbitux (cetuximab) is FDA approved for use in head and neck squamous cell carcinoma and KRAS wild-type, EGFR positive colorectal cancer (FDA.gov). |
DrugClasses | EGFR Antibody 60 |
CAS Registry Number | 205923-56-4 |
NCIT ID | C1723 |